Dow Chemical’s $30m award falls through Nautilus trapdoor
01-09-2015
On January 10, the US Supreme Court agreed to decide on so-called ambiguous patent claims in Nautilus v Biosig Instruments.
If you have already subscribed please login.
If you have any technical issues please email tech support.
US Supreme Court, Nautilus, Biosig, medical devices
